The Russian vaccine “EpiVacCorona” is effective against all mutations of the coronavirus infection, including against strains of the disease “delta” and “delta plus”. This was announced on Thursday, June 24, by the Director General of the Vector Center, whose scientists have developed this drug, Rinat Maksyutov, during the International Scientific and Practical Conference “Global Threats to Biological Security. Problems and Solutions “.
– All strains of coronavirus that are currently of concern, including delta and delta plus mutations, do not fall into the structure of the selected peptide. This peptide is the basis of the EpiVacCorona vaccine, therefore it is resistant to all changes in coronavirus infection, he said.
As reported by the website kp.ru, on the eve of the development director of the Chumakov Center, Konstantin Chernov, said that the structure of the genome of the Indian strain of coronavirus infection does not prevent the use of the Russian vaccine “KoviVac” to protect against it.
